11.10.2024 10:50:03
|
Hardman & Co Q&A on Chesnara plc (CSN): 2024 interim results a steady performance
Hardman & Co Research
Hardman & Co analyst interview | Life assurance Q&A on Chesnara plc (CSN) | 2024 interim results a steady performance Chesnara plc is the topic of conversation when Hardman & Co analyst, Brian Moretta joins DirectorsTalk. In this interview with Brian, key insights are provided on Chesnara plc following the release of its 2024 interim results. The interview touches on Chesnara’s steady performance, factors affecting Economic Value, operational challenges in Sweden, the company’s recent acquisition activity, and its commitment to delivering long-term shareholder returns through sustained dividend growth. The interview offers a detailed breakdown of the company’s financial health and outlook for future growth. Listen to the interview here.
If you are interested in meeting the company, you can register your interest here
Hardman & Co Research can be accessed for free under MiFID. Please click here to read the statement. About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.
Dissemination of a CORPORATE NEWS, transmitted by EQS Group. |
2007041 11-Oct-2024
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Chesnara PLCmehr Nachrichten
11.10.24 |
Hardman & Co Q&A on Chesnara plc (CSN): 2024 interim results a steady performance (EQS Group) | |
01.10.24 |
Hardman Talks Video | Chesnara plc (CSN): Presentation and Q&A with Management (EQS Group) | |
26.09.24 |
Hardman & Co Research on Apax Global Alpha (APAX): 1H’24 deal activity coming back strongly (EQS Group) |